BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doğanlar O, Doğanlar ZB, Delen E, Doğan A. The role of melatonin in angio-miR-associated inhibition of tumorigenesis and invasion in human glioblastoma tumour spheroids. Tissue Cell 2021;73:101617. [PMID: 34418770 DOI: 10.1016/j.tice.2021.101617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Wang C, Choi WS. Use of Melatonin in Cancer Treatment: Where Are We? Int J Mol Sci 2022;23:3779. [PMID: 35409137 DOI: 10.3390/ijms23073779] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Chen S, Tu Y, Yuan H, Shi Z, Guo Y, Gong W, Tu S. Regulatory functions of miR‑200b‑3p in tumor development (Review). Oncol Rep 2022;47:96. [PMID: 35322861 DOI: 10.3892/or.2022.8307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Bastani S, Akbarzadeh M, Rastgar Rezaei Y, Farzane A, Nouri M, Mollapour Sisakht M, Fattahi A, Akbarzadeh M, Reiter RJ. Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved. Int J Mol Sci 2021;22:10874. [PMID: 34639215 DOI: 10.3390/ijms221910874] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]